AMERICAS

Aspen’s presence in the Americas is dominated by the businesses in Latin America. Mexico and Brazil are the largest contributors to regional performance. Aspen provides a range of trusted brands across prescription, hospital and over-the-counter (“OTC”) medicines and operates one finished dose form manufacturing facility in Brazil.

Key Countries

Brazil
Canada
Chile
Colombia
Ecuador
Mexico
USA

KEY BRANDS

Brand		Therapeutic category
Diprivan		General anaesthetic
Meticorten		Glucocorticoid immunosuppressant
Milk of Magnesia		OTC
Ovestin		Estrogen hormone replacement
Xylocaine		Regional anaesthetic

NUMBER OF PERMANENT EMPLOYEES

768

June 2021

773

June 2020

STATISTICS

Number of products launched:

3

(2020: 8)

Number of product recalls:

1

(2020: 1)

Average staff turnover:

14%

(2020: 26%)

Number of work-related fatalities:

Nil

(2020: Nil)

Sales representatives:

255

(2020: 256)

Revenue	2021 R’million	2020 (CER) R’million	Change %
Regional Brands	2 613	2 399	9
Sterile Focus Brands	1 393	1 283	9
Total	4 006	3 682	9

Note: Commercial Pharmaceuticals revenue by customer geography.

The Mexican pharmaceutical market grew 14,0% to USD10,8 billion MAT* June 2021, positively impacted by double-digit growth across the generic and ethical markets.
Pharmaceutical sales across the total Spanish Latin America market grew 20% to USD21,3 billion MAT June 2021.

Source: IQVIA – June 2021
*MAT = Moving annual total